Last Update 15:40
Wednesday, 27 January 2021

EU, CureVac in talks on 225 mln doses of potential COVID-19 vaccine

'Today we concluded talks with the European company CureVac to increase the chances of finding an effective coronavirus vaccine,' EU Health Commissioner Stella Kyriakides said

Reuters , Thursday 20 Aug 2020
Stella Kyriakides
FILE PHOTO: EU commissioner for Health, Stella Kyriakides delivers a speech during a joint press conference on the European Green Deal Biodiversity and Farm to Fork Strategies with European Commission Vice President and EU commissioner for Environment and Oceans, at EU headquarters in Brussels, Belgium May 20, 2020. (Photo: Reuters)
Share/Bookmark
Views: 2016
Share/Bookmark
Views: 2016

The European Commission said on Thursday it had concluded exploratory talks with CureVac regarding the purchase of 225 million doses of the German biotech firm's potential COVID-19 vaccine.

"Today we concluded talks with the European company CureVac to increase the chances of finding an effective coronavirus vaccine," EU Health Commissioner Stella Kyriakides said.

The EU will now begin talks on a contract with CureVac aimed at securing the supply of its potential vaccine for all 27 EU member states should the shot prove safe and effective against COVID-19.

Short link:

 

Latest

© 2010 Ahram Online.